Skip to main navigation
Skip to search
Skip to main content
Research Nebraska Home
Help & FAQ
Home
Profiles
Research units
Facilities and Equipment
Research output
Projects
Activities
Prizes
Search by expertise, name or affiliation
How is it best to treat early rheumatoid arthritis patients?
James R. O'Dell
Rheumatology
Great Plains IDeA-CTR
Rheumatology, Nebraska Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
23
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'How is it best to treat early rheumatoid arthritis patients?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Tetracycline
100%
Health Systems
100%
Rheumatoid Arthritis Patients
100%
Rheumatoid Arthritis
100%
Diagnosis Treatment
100%
Treatment Options
100%
Early Treatment
100%
Early Diagnosis
100%
Disease-modifying Antirheumatic Drugs (DMARDs)
100%
Rheumatoid Arthritis Treatment
100%
New Treatment Options
100%
Etanercept
100%
Infliximab
100%
Tumour Necrosis Factor Inhibitor (TNFi)
100%
Leflunomide
100%
Early Rheumatoid Arthritis
100%
Optimal Care
100%
New Evidence
100%
Early Arthritis
100%
Old Drugs
100%
Pharmacology, Toxicology and Pharmaceutical Science
Rheumatoid Arthritis
100%
Arthritis
33%
Disease Modifying Antirheumatic Drug
33%
Tetracycline Derivative
33%
Infliximab
33%
Etanercept
33%
Tumor Necrosis Factor Inhibitor
33%
Leflunomide
33%
Immunology and Microbiology
Inflammatory Arthritis
100%
Arthritis
33%
Leflunomide
33%
Infliximab
33%
Disease-Modifying Antirheumatic Drug
33%
TNF Inhibitor
33%
Etanercept
33%
Nursing and Health Professions
Tetracycline Derivative
33%